| Copper | Approved Investigational | FBXO8 | 26269 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of FBXO8 mRNA | 4q34.1 | |
| Copper | Approved Investigational | FBXW10 | 10517 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of FBXW10 mRNA | 17p11.2 | |
| Copper | Approved Investigational | FCHO1 | 23149 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of FCHO1 mRNA | 19p13.11 | |
| Copper | Approved Investigational | FDPS | 2224 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of FDPS mRNA | 1q22 | |
| Copper | Approved Investigational | FEM1C | 56929 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of FEM1C mRNA | 5q22.3 | |
| Copper | Approved Investigational | FEN1 | 2237 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of FEN1 mRNA | 11q12.2 | |
| Copper | Approved Investigational | FERMT2 | 10979 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of FERMT2 mRNA | 14q22.1 | |
| Copper | Approved Investigational | FGFR1OP2 | 26127 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of FGFR1OP2 mRNA | 12p11.23 | |
| Copper | Approved Investigational | FHL2 | 2274 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of FHL2 mRNA | 2q12.2 | |
| Copper | Approved Investigational | FICD | 11153 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of FICD mRNA | 12q23.3 | |
| Copper | Approved Investigational | FKBP1A | 2280 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of FKBP1A mRNA | 20p13 | |
| Copper | Approved Investigational | FKBP5 | 2289 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of FKBP5 mRNA | 6p21.31 | |
| Copper | Approved Investigational | FKBP7 | 51661 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of FKBP7 mRNA | 2q31.2 | |
| Copper | Approved Investigational | FLCN | 201163 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of FLCN mRNA | 17p11.2 | |
| Copper | Approved Investigational | FLNB | 2317 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of FLNB mRNA | 3p14.3 | |
| Copper | Approved Investigational | FLNC | 2318 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of FLNC mRNA | 7q32.1 | |
| Copper | Approved Investigational | FLVCR2 | 55640 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of FLVCR2 mRNA | 14q24.3 | |
| Copper | Approved Investigational | FN1 | 2335 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of FN1 mRNA | 2q35 | |
| Copper | Approved Investigational | FNDC11 | 79025 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of FNDC11 mRNA | 20q13.33 | |
| Copper | Approved Investigational | FNIP1 | 96459 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of FNIP1 mRNA | 5q31.1 | |
| Copper | Approved Investigational | FOS | 2353 |
downregulated | Copper results in decreased expression of FOS mRNA | 14q24.3 | |
| Copper | Approved Investigational | FOS | 2353 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of FOS mRNA | 14q24.3 | |
| Copper | Approved Investigational | FOS | 2353 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of FOS mRNA | 14q24.3 | |
| Copper | Approved Investigational | FOS | 2353 |
upregulated | [Organoselenium Compounds binds to Copper] which results in increased expression of FOS mRNA | 14q24.3 | |
| Copper | Approved Investigational | FOSB | 2354 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of FOSB mRNA | 19q13.32 | |